Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

elderly women_iStock
News | Clinical Trials | June 09, 2017

The milestone Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study is working with government and academic...

advanced visualization
News | Molecular Imaging | June 09, 2017

The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens...

Siemens Healthineers Debuts Symbia Intevo Bold SPECT/CT
News | SPECT-CT | June 08, 2017

Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine &...

MIM Software Inc. Announces Updates to MIM Encore
Technology | Remote Viewing Systems | May 31, 2017

May 31, 2017 — MIM Software Inc. recently announced significant updates to its MIM Encore solution for viewing...

News | Enterprise Imaging | May 25, 2017

May 25, 2017 — At the 2017 annual meeting of the Society for Imaging Informatics in Medicine (SIIM), June 1-3 in...

Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers | May 22, 2017

May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced...

FALCON Trial of Fluciclovine PET/CT Imaging Stops Recruitment after Successful Interim Analysis
News | Radiopharmaceuticals and Tracers | May 15, 2017

May 15, 2017 — Blue Earth Diagnostics announced that the Trial Steering Committee recommended further recruitment be...

Study Reveals Low Adoption of IAEA Recommendations for Reduced Nuclear Cardiology Radiation Exposure
News | Radiation Dose Management | May 12, 2017

May 12, 2017 — A study in 65 countries has revealed low adoption of International Atomic Energy Agency (IAEA)...

Large Nuclear Cardiology Laboratory Slashes Radiation Dose 60 Percent in Eight Years
News | Radiation Dose Management | May 11, 2017

May 11, 2017 — A large nuclear cardiology laboratory in Missouri has slashed its average...

A low-dose lung CT scan can be used to help detect mesothelioma.

An example of a low-dose CT scan of the lungs, showing lung cancer. Image courtesy of Toshiba.

Feature | Lung Cancer | May 05, 2017 | Alison Grimes

The term mesothelioma was coined in 1909, just a few years after the introduction of medical X-ray imaging. The term...

PET/CT

The Philips Ingenuity TF PET/CT system leverages multiple technologies.

Feature | Radiation Oncology | May 05, 2017 | By Lola Koktysh

The continuum of personalized care, covering individualized prevention and therapy, translates into multiple changes...

Videos | Radiology Business | May 03, 2017

Kim A. Williams, Sr., M.D., chief of cardiology at Rush University Medical Center, Chicago and former president of...

PET/CT Helps Predict Therapy Effectiveness in Pediatric Brain Tumors

FIGURE: MRI AND PET-MRI FUSION IMAGES OF PATIENTS WITH DIPG. Top row: Zr-89-bevacizumab PET (144 hrs p.i.) fused with T1-Gd weighted MRI per patient; middle row: T1-Gd weighted MRI; lower row: T2-weighted/FLAIR MR-images. Five tumors show variable uptake of Zr-89-bevacizumab (white arrows), with both PET negative and positive areas within each tumor. Two primary tumors are completely PET negative (Fig. 1C and 1E), while the T2 weighted images show tumor infiltration in the whole pons of both patients. In the middle row, the red arrows represent the areas of contrast enhancement within the tumor. In four out of five primary tumors, the PET-positive area corresponds with the contrast-enhancing area on MRI of the tumors (Fig. 1A, 1B, 1F and 1G). In Fig. 1C, the tumor shows an MRI contrast-enhancing area, while there is no Zr-89-bevacizumab uptake. Fig. 1D shows a PET positive tumor, while no Gd-enhancement is observed on MRI. Credit: Sophie Veldhuijzen van Zanten and Marc Jansen, VU University Medical Center, Amsterdam, The Netherlands.

News | PET-CT | May 02, 2017

May 2, 2017 — In a first-ever molecular drug-imaging study in children, researchers in The Netherlands used whole-...

Australian Team Finds New Method for Producing PET Radiotracers in Higher Radiochemical Yields
News | Radiopharmaceuticals and Tracers | April 28, 2017

April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the...

Videos | Nuclear Imaging | April 28, 2017

David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American...

News | Prostate Cancer | April 24, 2017

April 24, 2017 — Cancer Targeted Technology recently announced it is focusing on small molecules that target pivotal...

SPECT/CT Imaging Test Shown Accurate in Ruling Out Kidney Cancers
News | SPECT Imaging | April 24, 2017

April 24, 2017 — The latest in a series of studies led by researchers at Johns Hopkins Medicine shows that addition...

University of Missouri Research Reactor Files to Start U.S. Production of Medical Isotopes
News | Radiopharmaceuticals and Tracers | April 13, 2017

April 13, 2017 — The University of Missouri Research Reactor (MURR) and its partners Nordion and General Atomics (GA...

IBA Molecular and Mallinckrodt Nuclear Medicine Merge to Become Curium
News | Radiopharmaceuticals and Tracers | April 11, 2017

April 11, 2017 — IBA Molecular announced that it has merged with previous acquisition Mallinckrodt...

PET
Feature | Radiology Imaging | April 11, 2017 | By Greg Freiherr